OLMA Jul 2024 30.000 call
| Previous close | 1.1200 |
| Open | 0.3000 |
| Bid | 0.1000 |
| Ask | 1.2000 |
| Strike | 30.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.3000 - 1.1200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Barrons.comTruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors
Rorema Beheer disclosed a large position in healthcare IT solutions firm TruBridge. PL Capital Advisors increased its stake in regional bank Evans Bancorp.
GlobeNewswireOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company granted stock options to four new employees to purchase an aggregate of 51,600 shares of the Company's common stock, effective as of June 3, 2024. These awards were approved by the Compensation Comm
- GlobeNewswire
Olema Oncology to Participate in Upcoming Investor Conferences in June
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Wednesday, June 5, 2024, at 2:00 p.m. ET Location: Marriott Marquis in New York, NY
